Reason for request
Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
Clinical Benefit
| Insufficient |
The actual benefit of CHONDROSULF 400 mg capsules and granules is insufficient to justify reimbursement by National Insurance. |
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
KZHkmsdLvDvbnzuh
